Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is clear cell adenocarcinoma of the vagina and cervix?
Clear cell adenocarcinoma is a rare cancer that arises from gland-like cells in the vagina or cervix and gets its name from the clear appearance of its cells under the microscope. It became well known because of a historical link: daughters of women who took a synthetic estrogen called diethylstilbestrol (DES) during pregnancy between roughly the 1940s and early 1970s had a higher risk of developing it as teenagers and young adults. Because DES has not been used in pregnancy for many years, today the cancer is increasingly seen in older women with no DES exposure. It can cause abnormal vaginal bleeding or discharge and is often found during a pelvic exam or follow-up. Treatment combines surgery and radiation, and outcomes are generally good, especially when the cancer is found early.
The main types
Doctors group clear cell adenocarcinoma of the vagina and cervix by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Vaginal clear cell adenocarcinoma | Arises in the lining of the vagina, classically in the upper vagina; the form most associated with prenatal DES exposure in younger patients. |
| Cervical clear cell adenocarcinoma | Arises in the cervix; can occur with or without DES exposure and, unlike most cervical cancers, is not driven by HPV. |
Staging, in plain terms
These cancers are staged with the FIGO system used for gynecologic cancers, which describes how far the tumor has grown and whether it has spread — rather than a single number for size alone. Early stages mean the cancer is confined to the vagina or cervix; later stages mean it has grown into nearby tissues, the pelvic wall, lymph nodes, or distant organs. The stage, together with the exact location and how deep the tumor goes, guides whether surgery, radiation, or both are used.
| FIGO stage (gynecologic) plus location | What it generally means |
|---|---|
| Early (confined) | Limited to the vagina or cervix. Often curable with surgery or radiation, sometimes with fertility-sparing options in carefully selected young patients. |
| Locally advanced | Grown into nearby tissues or pelvic lymph nodes. Usually treated with radiation — external beam plus internal (brachytherapy) — often with chemotherapy to make radiation work better. |
| Advanced / metastatic | Spread to distant organs. Treated with chemotherapy and radiation to control disease and relieve symptoms, with care tailored to the individual. |
The standard of care
Clear Cell Adenocarcinoma of the Vagina and Cervix is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery for early disease
Removing the tumor — and sometimes the uterus, upper vagina, and nearby lymph nodes — can cure early cancers. In selected young women with small tumors, more limited, fertility-sparing surgery may be considered at expert centers.
Radiation therapy
Radiation, often combining external beams with internal brachytherapy, is a primary curative treatment, especially for tumors that are larger, harder to remove, or where preserving the organ is preferred. It is also used after surgery when there are high-risk features.
Chemoradiation for locally advanced disease
For cancers that have grown beyond the immediate area, low-dose chemotherapy is given alongside radiation to make the radiation more effective, similar to how other gynecologic cancers are treated.
Long-term follow-up
Because these cancers can recur years later (and DES-exposed patients may have other findings), regular pelvic exams and surveillance are an important part of care.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide and the tumor shrinks. For clear cell adenocarcinoma of the vagina or cervix, radiation is one of the main curative treatments. It is often delivered in two complementary ways: external beams that treat the whole area and any lymph nodes, and brachytherapy, in which a radiation source is placed right at the tumor to give a very high local dose while sparing nearby organs like the bladder and rectum. Modern image guidance and intensity-modulated techniques shape the dose precisely. Radiation is painless during delivery, given over a planned schedule, and external-beam treatment leaves no radioactivity in the body.
The main ways radiation is delivered for clear cell adenocarcinoma of the vagina and cervix:
External-beam radiation (IMRT/IGRT)
Shaped, image-guided beams treat the pelvis and the tumor while sparing the bladder, rectum, and bowel, lowering side effects.
Brachytherapy (internal radiation)
A radiation source is placed inside the vagina or close to the tumor, delivering a high, precise dose to the cancer over a short distance while sparing surrounding tissue — a powerful tool for these cancers.
Concurrent chemoradiation
A radiation-sensitizing chemotherapy is given during radiation so that each treatment damages cancer cells more effectively together than either alone.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
The DES connection and changing patient population: Long-term follow-up of the DES-exposed cohort confirmed the increased risk of clear cell adenocarcinoma and tracked its decline as DES use ended; today the cancer increasingly occurs in older women without DES exposure.[1]
New England Journal of Medicine / National Cancer Institute DES follow-up studies
Distinct biology from common cervical cancer: Molecular studies show cervical clear cell adenocarcinoma is generally not caused by HPV, unlike most cervical cancers, which has implications for screening and prevention and supports individualized treatment.[2]
Gynecologic Oncology pathology and molecular series
Favorable outcomes with combined treatment: Series of patients treated with surgery, radiation including brachytherapy, and chemoradiation for advanced disease report good cure rates for early-stage tumors and meaningful control for locally advanced disease.[3]
International gynecologic-oncology treatment series
Common questions
I was exposed to DES before birth — should I be screened? Women exposed to DES in the womb are advised to have regular pelvic exams that specifically check the vagina and cervix, because their risk is higher than average even though the cancer remains rare. Tell your gynecologist about DES exposure so screening can be tailored. Most DES-exposed women never develop this cancer.
Is this cancer caused by HPV like most cervical cancers? No. Clear cell adenocarcinoma is generally not linked to HPV, which makes it different from the common types of cervical cancer. That is one reason it can occur in people who have had normal Pap and HPV tests, and why any unusual bleeding should be checked.
Will treatment affect fertility? It can, because surgery and pelvic radiation may affect the reproductive organs. For some young women with small, early tumors, fertility-sparing approaches may be possible at expert centers. Ask your care team about fertility preservation before treatment begins.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- New England Journal of Medicine / National Cancer Institute DES follow-up studies (no indexed identifier — see your care team) ↩
- Gynecologic Oncology pathology and molecular series (no indexed identifier — see your care team) ↩
- International gynecologic-oncology treatment series (no indexed identifier — see your care team) ↩